Alpha 2.0
Login Register
» Authors » Maarten F Schim van der Loeff

Maarten F Schim van der Loeff

Explore the profile of Maarten F Schim van der Loeff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 211
Citations 2799
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Science
Top 10 Co-Authors
Henry J C de Vries
Maria Prins
Udi Davidovich
Anders Boyd
Elske Hoornenborg
Sylvia M Bruisten
Peter Reiss
Titia Heijman
Vita W Jongen
Marianne A B van der Sande
Published In
AIDS
Sex Transm Dis
PLoS One
BMC Infect Dis
J Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Health system barriers to HPV-vaccination in adolescent females with a Moroccan or Turkish migration background in the Netherlands: A qualitative study
van Enter B, de Zeeuw J, Bakar O, Bakhlakh S, Schim van der Loeff M, Boersma C, et al.
Vaccine . 2025 Feb; 50:126827. PMID: 39908781
Introduction: In the Netherlands HPV-vaccination uptake is low among females with a Moroccan or Turkish migration background. The aim of this study was to identify health system barriers to HPV-vaccine...
2.
A biomarker profile reflective of preserved thymic function is associated with reduced comorbidities in ageing people with HIV: an AGEhIV Cohort analysis
Vanbellinghen M, Boyd A, Kootstra N, Schim van der Loeff M, Van Der Valk M, Reiss P
J Infect Dis . 2024 Dec; PMID: 39658325
Background: People with HIV (PWH) experience a higher burden of ageing-associated comorbidities, the underlying mechanisms of which remain to be fully elucidated. We aimed to identify profiles based on immune,...
3.
Increase in infections after ending COVID-19 lockdown measures in Amsterdam, the Netherlands
Teker B, Schim van der Loeff M, Boyd A, Hoornenborg E, Stam A, de Vries H, et al.
Sex Transm Infect . 2024 Dec; PMID: 39643436
Objective: Various European countries noted increasing (Ng) positivity among cis-gender women and heterosexual men. We assessed changes over time in Ng among men who exclusively have sex with men (MSM),...
4.
[Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort]
van den Elshout M, Wijstma E, Boyd A, Jongen V, Coyer L, Anderson P, et al.
Ned Tijdschr Geneeskd . 2024 Oct; 168. PMID: 39474835
Objective: HIV can be effectively prevented by oral HIV pre-exposure prophylaxis (PrEP). When PrEP was introduced, there was apprehension that condom use would decrease and STIs would increase. The purpose...
5.
Effectiveness of bivalent HPV vaccination against genital HPV DNA-positivity of a catch-up campaign at age 13-16 years compared to routine vaccination at age 12 years: a biennial repeated cross-sectional study
Kusters J, Schim van der Loeff M, van Benthem B, King A, de Melker H, Heijman T, et al.
BMC Med . 2024 Oct; 22(1):469. PMID: 39407233
Background: The Netherlands is one of few countries worldwide which has used the bivalent HPV vaccine for girls-only for over a decade. This allows assessment of vaccine effectiveness (VE) against...
6.
Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized preexposure prophylaxis care in Amsterdam, the Netherlands
Wijstma E, Jongen V, Boyd A, de Vries H, Schim van der Loeff M, Prins M, et al.
AIDS . 2024 Oct; 39(1):75-84. PMID: 39352137
Objective: The Dutch HIV preexposure prophylaxis (PrEP) pilot provided subsidized PrEP care to maximum 2900 individuals at a time in Amsterdam. Populations with expected barriers to accessing PrEP elsewhere were...
7.
Use of passive samplers as sewage surveillance tool to monitor a hepatitis A outbreak at a school in Amsterdam, the Netherlands, Oct 2022 - March 2023
de Jong M, Schim van der Loeff M, Schilperoort R, Vennema H, van der Weijden C, Langeveld J, et al.
BMC Infect Dis . 2024 Sep; 24(1):1044. PMID: 39333937
Background: Enteric hepatitis A virus (HAV) infections during childhood are often asymptomatic but may cause severe illness in adults. To improve public health surveillance we assessed the applicability of sewage...
8.
Changes in Genital Human Papillomavirus (HPV) Prevalence During 12 Years of Girls-Only Bivalent HPV Vaccination: Results From a Biennial Repeated Cross-sectional Study
Kusters J, Schim van der Loeff M, Heijne J, King A, de Melker H, Heijman T, et al.
J Infect Dis . 2024 Sep; 231(1):e165-e176. PMID: 39271142
Background: Between 2009-2021, bivalent human papillomavirus (HPV) vaccination was offered to girls in the Netherlands. We studied the impact of girls-only HPV vaccination on genital HPV prevalence among young adults....
9.
Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls
Verburgh M, Boyd A, Schim van der Loeff M, Bakker M, Wit F, Van Der Valk M, et al.
Open Forum Infect Dis . 2024 Jul; 11(7):ofae380. PMID: 39070044
Background: Little is known about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infection in people with human immunodeficiency virus (HIV; PWH) with vaccine-induced or hybrid immunity....
10.
Prevalence and risk factors for HPV seropositivity and anogenital DNA positivity among men who have sex with men: a repeated cross-sectional study
Kusters J, Obels I, van der Klis F, King A, Heijman T, Heijne J, et al.
Int J Infect Dis . 2024 May; 145:107094. PMID: 38777081
Objectives: This study aimed to assess associations of potential risk factors with human papillomavirus (HPV) seropositivity among men who have sex with men (MSM) and compare these to risk factors...